Gerry DeBiasi is a Partner at Kidd & Company (KCO), the private equity arm of the Kidd Family Office, where he focuses on developing and executing thesis-driven lower middle market investment strategies, with particular emphasis on multi-company acquisition and integration platforms. He has led KCO’s investments in – and led the board of – several notable portfolio companies, including Logistyx Technologies (named ACG Technology Deal of the Year), Brand Holdings (parent of Knockaround Sunglasses and Dr. Emil Nutrition), and Pierce Washington, an enterprise software systems integrator. Earlier in his tenure, he was also involved with KCO portfolio companies MedSource Technologies, iPacesetters, and Reladyne.
Prior to joining KCO, Gerry served on the executive leadership team at one of its portfolio companies, Chatham Technologies, as SVP of Business Development. He was responsible for corporate strategy, acquisitions & integration, and global client development – and played a key role in growing revenue from $153 million to more than $600 million in less than four years.
Earlier in his career, Gerry was a strategy consultant at Monitor Company, working in Boston, San Francisco, and Hong Kong. He also held roles at Fidelity Investments and the Federal Reserve Board of Governors and co-founded a specialty publishing company.
Gerry earned a BA in Economics, summa cum laude and Phi Beta Kappa, from Dartmouth College, and an MBA from Harvard Business School, earning honors recognition in the process. He has also served as Chairman of ACG Boston’s Family Office Committee and member of The Yard Ventures Fund Investment Committee.
